Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components

2001/08/01 by Takeshi Watanabe, T Watanabe, Yasunori Oda +7 · 7 citations
Medicine · #Neurofibromatosis and Schwannoma Cases #Myasthenia Gravis and Thymoma #Neuroblastoma Research and Treatments

paper · pdf · doi:10.1136/jcp.54.8.631

Abstract

AIMS: To compare the expression of immunohistochemical variables between benign and malignant components of malignant peripheral nerve sheath tumour (MPNST) arising within neurofibroma. METHODS: Eight cases of MPNST arising within a neurofibroma, associated with neurofibromatosis type 1 (NF1), were studied. The areas of MPNST and neurofibroma were compared immunohistochemically with regard to the expression of proliferative activity (MIB-1), growth factors, p53, bcl-2, neural cell adhesion molecule (N-CAM), and CD34. RESULTS: The expression of transforming growth factor beta 1 (TGF-beta 1), TGF-beta receptor type II, hepatocyte growth factor alpha (HGF-alpha), c-met, p53, and N-CAM was higher in the areas of MPNST than in the neurofibromatous areas in four, five, five, eight, five, and three of the eight cases, respectively. CD34 expression was lower in the areas of MPNST than in the neurofibroma areas in three of the eight cases. CONCLUSIONS: On the basis of these findings, TGF-beta 1, HGF-alpha, and p53 might be involved in the malignant transformation of neurofibroma to MPNST.

Cited by

• How does the Schwann cell lineage form tumors in NF1? [europepmc]
• Malignant peripheral nerve sheath tumor in neurobifromatosis type-1: two case reports. [europepmc]
• Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors. [europepmc]
• Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling. [europepmc]
• Extra-spinal sciatica and sciatica mimics: a scoping review. [europepmc]
• Malignant Peripheral Nerve Sheath Tumors: Latest Concepts in Disease Pathogenesis and Clinical Management. [europepmc]
• Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors. [europepmc]

Related

• Malignant peripheral nerve sheath tumours in neurofibromatosis 1
• Induced pluripotent stem cell–derived models of malignant nerve sheath tumor progression mimic glial to neuro-mesenchymal transition and uncover therapeutic opportunities
• Magnetic Resonance Tractography in Malignant Peripheral Nerve Sheath Tumor
• Peripheral nerve sheath tumors of the upper extremity and hand in patients with neurofibromatosis type 1: topography of tumors and evaluation of surgical treatment in 62 patients
• Management of peripheral nerve sheath tumors: 17 years of experience at Toronto Western Hospital